{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:05:44Z","timestamp":1791144344828,"version":"4.1.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,2]]},"DOI":"10.1097\/01.aids.0000194802.89540.e1","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T09:11:18Z","timestamp":1131613878000},"page":"2141-2148","source":"Crossref","is-referenced-by-count":264,"title":["Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design"],"prefix":"10.1097","volume":"19","author":[{"given":"Stephen D","family":"Lawn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon","family":"Myer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Orrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210130","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-199714000-00010","article-title":"Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy","volume":"11","author":"Brodt","year":"1997","journal-title":"AIDS"},{"key":"R2-11-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R3-11-20210130","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","article-title":"Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators","volume":"280","author":"Detels","year":"1998","journal-title":"JAMA"},{"key":"R4-11-20210130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"key":"R7-11-20210130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/431199","article-title":"Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature","volume":"41","author":"Ivers","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R9-11-20210130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200404090-00006","article-title":"Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa","volume":"18","author":"Coetzee","year":"2004","journal-title":"AIDS"},{"key":"R10-11-20210130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0140-6736(02)09330-3","article-title":"Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients\u2019 response, survival, and drug resistance","volume":"360","author":"Weidle","year":"2002","journal-title":"Lancet"},{"key":"R11-11-20210130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00126334-200501010-00003","article-title":"Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults","volume":"38","author":"Laurent","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 3","key":"R12-11-20210130","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/00002030-200317003-00002","article-title":"Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, C\u00f4te d'Ivoire","volume":"17","author":"Djomand","year":"2003","journal-title":"AIDS"},{"key":"R13-11-20210130","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1097\/00002030-200309050-00023","article-title":"Highly active antiretroviral therapy in resource-poor settings: the experience of M\u00e9decins sans Fronti\u00e8res","volume":"17","author":"Tassie","year":"2003","journal-title":"AIDS"},{"key":"R14-11-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(04)16586-0","article-title":"Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial","volume":"364","author":"Laurent","year":"2004","journal-title":"Lancet"},{"key":"R15-11-20210130","first-page":"458","article-title":"Antiretroviral therapy in a community clinic: early lessons from a pilot project","volume":"93","author":"Bekker","year":"2003","journal-title":"S Afr Med J"},{"key":"R19-11-20210130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/00002030-200405210-00009","article-title":"Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines","volume":"18","author":"Badri","year":"2004","journal-title":"AIDS"},{"key":"R20-11-20210130","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00002030-200203080-00011","article-title":"HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?","volume":"16","author":"Morgan","year":"2002","journal-title":"AIDS"},{"key":"R21-11-20210130","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/00002030-199512000-00008","article-title":"Survival after AIDS among Italian haemophiliacs with HIV infection. The Italian Group on Congenital Coagulopathies","volume":"9","author":"Ghirardini","year":"1995","journal-title":"AIDS"},{"key":"R22-11-20210130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002030-199303000-00017","article-title":"Improved survival from diagnosis of AIDS in adult cases in the United Kingdom and bias due to reporting delays","volume":"7","author":"Whitmore-Overton","year":"1993","journal-title":"AIDS"},{"key":"R23-11-20210130","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00002030-199810000-00013","article-title":"Disease progression and survival in HIV-1-infected Africans in London","volume":"12","author":"Del Amo","year":"1998","journal-title":"AIDS"},{"key":"R25-11-20210130","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00002030-200306130-00011","article-title":"Adherence is not a barrier to successful antiretroviral therapy in South Africa","volume":"17","author":"Orrell","year":"2003","journal-title":"AIDS"},{"key":"R26-11-20210130","first-page":"583","article-title":"AIDS in Africa: survival according to AIDS-defining illness","volume":"91","author":"Post","year":"2001","journal-title":"S Afr Med J"},{"key":"R27-11-20210130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/sti.76.3.193","article-title":"Survival by AIDS defining condition in rural Uganda","volume":"76","author":"Morgan","year":"2000","journal-title":"Sex Transm Infect"},{"key":"R28-11-20210130","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/00002030-199312000-00005","article-title":"The mortality and pathology of HIV infection in a West African city","volume":"7","author":"Lucas","year":"1993","journal-title":"AIDS"},{"key":"R29-11-20210130","first-page":"55","article-title":"Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997\u20131998","volume":"6","author":"Ansari","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"R30-11-20210130","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/bmj.308.6943.1531","article-title":"Contribution of tuberculosis to slim disease in Africa","volume":"308","author":"Lucas","year":"1994","journal-title":"Br Med J"},{"key":"R31-11-20210130","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1086\/344467","article-title":"Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy","volume":"35","author":"Jenny-Avital","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.aids.0000194802.89540.e1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T19:45:22Z","timestamp":1620935122000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200512020-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,2]]},"references-count":24,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000194802.89540.e1","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12,2]]}}}